|
|
| |
GSK Announces Joint Venture for Paediatric Vaccine
GlaxoSmithKline has formed a joint venture with Indian vaccines company Biological E to research and develop a six-in-one combination paediatric vaccine to help protect children in India and other developing countries from certain infectious diseases. More... |
|
| |
|
| |
Actavis Unveils Long-Term Growth Strategy
Actavis unveiled its long-term growth strategy this week and officially re-introduced itself under the Actavis name following the EUR 4.25-billion acquisition of the Actavis Group by Watson Pharmaceuticals in 2012. More... |
|
| |
Combined Oral Contraceptives Spark Safety Review
There are growing concerns regarding the safety of third- and fourth-generation combined oral contraceptives following media reports on blood clots associated with the use of more recently-introduced contraceptive products containing newer progestins, such as drospirenone, gestodene and desogestrel. More... |
|
| |
|
|
| Flexicon Liquid Filling |
FF30 Table-top Filling and Capping Machine
This semi-automatic filling and capping machine is ideal for flexible small scale production in diagnostics production, hospital pharmacies, R&D departments and general subcontract filling/finish companies. The speed of the FF30 is easily adjusted to match the working speed of the operator and liquids can be filled in volumes from 0.1ml to 100ml with +/-0.5% accuracy.  Read more |
 |
|
|
| Pharmapack Europe |
13-14 February 2013, Grande Halle de la Villette, Paris, France
How Innovations in Pharma Packaging and Drug Delivery Technologies Enhance Patient Safety and Compliance.  Read more
|
 |
|
|
|
|
|
|
| Which of the following has had the most significant advances in PAT over the last 5 years? |
|
Measurements devices placed at-, in- or on-line |
28% |
| |
|
Statistical and information technology tools |
24% |
| |
|
|
|
Scientific-systems approach for data analysis to control processes |
48% |
This week we would like to know...
What do you think is the main challenge facing manufacturers seeking to launch a new biosimilar?
|
|
|
| Contact Us |
Click here to contact editorial.
Click here to contact sales. |
|
